Stanford Medicine researchers have developed a blood test capable of detecting cancers, the ways cancer resists treatments ...

Valued at a market cap of $9.6 billion, Cambridge, Massachusetts-based Moderna, Inc. (MRNA) is a biotechnology company that ...

Pausing treatment during vaccination did not improve immunity in patients with chronic lymphocytic leukemia and should not be ...

Alarming Surge in Breast Cancer Among COVID Vaccinated Women Raises Questions** A staggering 1,000% increase in breast cancer cases has been reported among American women who received COVID-19 mRNA ...

In the early days of the COVID-19 pandemic, Moderna (NASDAQ: MRNA) was a top performer, from both a share-price and an ...

The “Make America Healthy Again” movement cheered when Robert F. Kennedy Jr. was confirmed as HHS secretary, but their wish ...

Some of Kennedy’s allies say he’s become almost inaccessible since his confirmation and complain that he’s made glacial progress advancing MAHA goals, such as halting mRNA-based COVID shots and ...

Advancements in mRNA vaccine technology are reshaping medicine, addressing challenges and expanding applications from ...

Researchers from the International Institute of Molecular and Cell Biology in Warsaw (IIMCB) have described a new mechanism ...

Despite the PNG award termination, GeoVax anticipates a milestone-rich 2025 across its portfolio. The Company will continue to engage with government and industry partners, pursue clinical trial ...

The U.S. government continues to end contracts related to the $5 billion Project NextGen initiative, this time terminating ...

In recent years, mRNA technology enabled the rapid development of vaccines to fight COVID-19, saving millions of lives.